Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Fabio Casciani, Maxwell T. Trudeau, Horacio J. Asbun, Chad G. Ball, Claudio Bassi, Stephen W. Behrman, Adam C. Berger, Mark P. Bloomston, Mark P. Callery, John D. Christein, Massimo Falconi, Carlos Fernandez-del Castillo, Mary E. Dillhoff, Euan J. Dickson, Elijah Dixon, William E. Fisher, Michael G. House, Steven J. Hughes, Tara S. Kent, John W. Kunstman, Giuseppe Malleo, Stefano Partelli, Christopher L. Wolfgang, Amer H. Zureikat, Charles M. Vollmer, George Van Buren, Wande B. Pratt, Ammara A. Watkins, Joal D. Beane, Ammar A. Javed, Katherine E. Poruk, Kevin C. Soares, Vicente Valero, Zhi V. Fong, John A. Stauffer, Mary E. Dilhoff, Ericka N. Haverick, Carl R. Schmidt, Robert H. Hollis, Jeffrey A. Drebin, Brett Ecker, Russell Lewis, Matthew McMillan, Benjamin Miller, Priya Puri, Thomas Seykora, Michael J. Sprys, Stacy J. Kowalsky, Laura Maggino, Roberto Salvia, Giulia Savegnago, Lorenzo Cinelli, Nigel B. Jamieson, Lavanniya K.P. Velu, Ronald R. Salem
Publikováno v:
Surgery. 170:1195-1204
Background: The association between intraoperative estimated blood loss and outcomes after pancreatoduodenectomy has, thus far, been rarely explored. Methods: In total, 7,706 pancreatoduodenectomies performed at 18 international institutions composin
Autor:
Nathan Bahary, Naomi Fei, Rajesh Ramanathan, Melissa E. Hogg, Sijin Wen, Brian A. Boone, Herbert J. Zeh, Amer H. Zureikat, Aatur D. Singhi, Michael T. Lotze
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1822-1829 (2021)
Clinical and Translational Science
Clinical and Translational Science
SMAD4, a tumor suppressor gene, is lost in up to 60%–90% of pancreatic adenocarcinomas (PDAs). Loss of SMAD4 allows tumor progression by upregulating autophagy, a cell survival mechanism that counteracts apoptosis and allows intracellular recycling
Autor:
Sidrah Khan, Caroline J. Rieser, Richard S. Hoehn, Samer Tohme, Ibrahim Nassour, David S. Medich, Amer H. Zureikat, Lindsay M. Sabik, Katherine Hrebinko
Publikováno v:
J Surg Res
Background Safety-net hospitals serve a vital role in society by providing care for vulnerable populations. Existing data regarding oncologic outcomes of patients with colon cancer treated at safety-net hospitals are limited and variable. The objecti
Autor:
Henry A. Pitt, Mohamed A. Adam, Amblessed E. Onuma, Joal D. Beane, Amer H. Zureikat, Andrew Billderback, Jeffrey D. Borrebach
Publikováno v:
The American Journal of Surgery. 222:29-34
The aim of this analysis is to compare the postoperative outcomes of resection and enucleation of small pancreatic neuroendocrine tumors (PNETs).The 2014-17 American College of Surgeons-NSQIP dataset was queried. Patients undergoing pancreatoduodenec
Autor:
Nathan Bahary, Mazen S. Zenati, M.E. Hogg, Asmita Chopra, Herbert J. Zeh, David L. Bartlett, Joal D. Beane, Amer H. Zureikat
Publikováno v:
Annals of Surgical Oncology. 28:7759-7769
A positive microscopic margin (R1) following resection of pancreatic ductal adenocarcinoma (PDAC) can occur in up to 80% of patients and is associated with reduced survival and increased recurrence. Our aim was to characterize the impact of neoadjuva
Autor:
Alessandro Paniccia, Derek Barclay, Yoram Vodovotz, Jacob C. Hodges, Michael T. Lotze, Pranav Murthy, Amer H. Zureikat, Brian A. Boone, Randall E. Brand, Ruben Zamora, Kenneth K. Lee, Asmita Chopra, Richard L. Simmons
Publikováno v:
J Immunother
Despite its increased application in pancreatic ductal adenocarcinoma (PDAC), complete response to neoadjuvant therapy (NAT) is rare. Given the critical role of host immunity in regulating cancer, we sought to correlate baseline inflammatory profiles
The Role of Simulation in Attaining Proficiency in Minimally Invasive Hepatopancreatobiliary Surgery
Autor:
Cameron Schlegel, Amer H. Zureikat
Publikováno v:
Journal of Laparoendoscopic & Advanced Surgical Techniques. 31:561-564
The implementation of robotic surgery in the field of hepato-pancreato-biliary (HPB) has been a slow but significant process. HPB procedures offer a unique challenge when for new technologies, as the surgeries themselves are complex, with long learni
Autor:
Melissa E. Hogg, Sarwat B. Ahmad, Ahmad Hamad, Amer H. Zureikat, T. Peter Kingham, Jin He, Mary Joe K. Rice, Herbert J. Zeh, Cecilia Chang, Jose M. Pimiento
Publikováno v:
Ann Surg Oncol
PURPOSE: To implement a mastery-based robotic surgery curriculum using virtual reality (VR) and inanimate reality (IR) drills at multiple Complex General Surgical Oncology (CGSO) fellowships. METHODS: A prospective study of curriculum feasibility and
Autor:
Caroline J. Rieser, Richard S. Hoehn, Mazen Zenati, Lauren B. Hall, Eliza Kang, Amer H. Zureikat, Andrew Lee, Melanie Ongchin, Matthew P. Holtzman, James F. Pingpank, David L. Bartlett, M. Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology
Ann Surg Oncol
Ann Surg Oncol
Background Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS HIPEC) can offer significant survival advantage for select patients with colorectal peritoneal metastases (CRPM). Low socioeconomic status (SES) is implicated in di
Autor:
Ibrahim Nassour, Kenneth K. Lee, Samer Tohme, Christof Kaltenmeier, Sidrah Khan, Amer H. Zureikat, Alessandro Paniccia, Samer AlMasri, Richard S. Hoehn, Katherine Hrebinko
Publikováno v:
Pancreas
Objectives The objective of this study was to create a composite measure, optimal oncologic surgery (OOS), for patients undergoing distal pancreatectomy for pancreatic adenocarcinoma and identify factors associated with OOS. Methods Adult patients un